Active, Not Recruiting
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
NCT04562766
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
- UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
- The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States